サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1339159

研究機関における非ヒト霊長類の前臨床試験の世界市場、シェア、規模、動向、産業分析レポート：用途別地域別、セグメント別予測、2023年～2032年

Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Share, Size, Trends, Industry Analysis Report, By Application (Infectious Disease, Immunological Disease, Cancer, Others) By Region; Segment Forecast, 2023 - 2032

出版日
ページ情報
英文 118 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
研究機関における非ヒト霊長類の前臨床試験の世界市場、シェア、規模、動向、産業分析レポート：用途別地域別、セグメント別予測、2023年～2032年
出版日: 2023年07月23日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、研究機関における非ヒト霊長類の前臨床試験市場規模は、2032年までに1億855万3,860米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

世界の研究機関における非ヒト霊長類の前臨床試験は、新薬やワクチンの開発に不可欠なステップであり、CROはそのような試験を実施するためのコスト効率の高いソリューションを提供しています。最近のゲノミクスやその他の技術の進歩により、非ヒト霊長類の生物学に対する理解が深まり、前臨床試験における非ヒト霊長類の使用が容易になりました。しかし、研究における非ヒト霊長類の使用は依然として議論の的となっており、動物を使用しない前臨床試験の代替法の開発動向が高まっています。

最近のゲノミクスやその他の技術の進歩により、非ヒト霊長類の生物学的理解が深まり、トランスレーショナルリサーチのための非ヒト霊長類モデルの開発が改善されてきました。これらの進歩は、前臨床試験における非ヒト霊長類の使用も容易にし、新薬やワクチンの安全性と有効性をより包括的に評価することを可能にしました。

北米のCROにおける前臨床試験における非ヒト霊長類は、医薬品開発において不可欠なステップとなっています。新しい技術の統合とトランスレーショナルリサーチのための非ヒト霊長類モデルのアップグレードにより、非ヒト霊長類前臨床試験の精度と有効性が向上しました。

非臨床試験における非ヒト霊長類の使用は、倫理的な懸念から依然として議論の的となっていますが、CROは、研究に使用される動物の福祉を確保するために、厳格な倫理ガイドラインと規制を遵守しています。さらにCROは、臨床試験に進む前に、前臨床試験が安全性と有効性の要件を満たしていることを確認するために、規制当局と緊密に連携しています。

欧州のCROは、動物福祉を確保するために厳格な倫理ガイドラインと規制に従い、規制機関は前臨床研究の安全性と有効性を監督しています。非臨床試験における非ヒト霊長類の使用は依然として議論の的となっているが、これらの試験は依然として医薬品開発に不可欠なステップです。

トランスレーショナルリサーチのために非ヒト霊長類モデルをアップグレードする傾向が強まっており、特定の疾患表現型を持つ非ヒト霊長類の使用に焦点が当てられています。例えば、アルツハイマー病、パーキンソン病、HIV感染症の非ヒト霊長類モデルは、これらの疾患の病因をよりよく理解し、新しい治療法を試験するために開発されました。

しかし、前臨床試験における非ヒト霊長類の使用は依然として議論の的となっており、動物愛護活動家たちは動物福祉に関する懸念を表明し続けています。多くの団体が、動物を使用しない前臨床試験の代替法の開発を求めています。

研究機関における非ヒト霊長類の前臨床試験の世界市場調査レポートハイライト

研究目的で非ヒト霊長類（非ヒト霊長類）ベースの前臨床試験を使用することへの関心の高まりが、この分野の成長を大きく後押ししています。

北米では、研究機関における非ヒト霊長類の前臨床試験が、研究開発およびセンター間での特定の表現型を持つ動物のコホートの同定に定期的に実施され、大きな成長を示しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の研究機関における非ヒト霊長類の前臨床試験市場洞察

  • 研究機関における非ヒト霊長類の前臨床試験市場- 業界スナップショット
  • 研究機関における非ヒト霊長類の前臨床試験市場力学
    • 促進要因と機会
      • 非ヒト霊長類前臨床試験での採用増加につながるCRISPRテクノロジーの革新
      • 高齢者人口の増加と対象疾患の有病率の上昇
    • 抑制要因と課題
      • 高額な手続き費用と曖昧な規制枠組みの存在
  • PESTLE分析
  • バリューチェーン分析
  • ヒト以外の霊長類受託研究機関における前臨床研究業界動向
  • COVID-19感染症の影響分析

第5章 世界の研究機関における非ヒト霊長類の前臨床試験市場、用途別

  • 主な調査結果
  • イントロダクション
  • 感染症
  • 免疫疾患
  • がん
  • 循環器疾患
  • 代謝性疾患
  • 遺伝病
  • 呼吸器疾患
  • 神経疾患
  • 女性関連の病気
  • その他

第6章 世界の研究機関における非ヒト霊長類の前臨床試験市場、地域別

  • 主な調査結果
  • イントロダクション
    • 研究機関における非ヒト霊長類の前臨床試験市場評価、地域別、2019-2032年
  • 研究機関における非ヒト霊長類の前臨床試験市場-北米
    • 北米：研究機関における非ヒト霊長類の前臨床試験市場、用途別、2019～2032年
    • 研究機関における非ヒト霊長類の前臨床試験市場-米国
    • 研究機関における非ヒト霊長類の前臨床試験市場- カナダ
  • 研究機関における非ヒト霊長類の前臨床試験市場- 欧州
    • 欧州：研究機関における非ヒト霊長類の前臨床試験市場、用途別、2019～2032年
    • 研究機関における非ヒト霊長類の前臨床試験市場- 英国
    • 研究機関における非ヒト霊長類の前臨床試験市場- フランス
    • 研究機関における非ヒト霊長類の前臨床試験市場- ドイツ
    • 研究機関における非ヒト霊長類の前臨床試験市場- イタリア
    • 研究機関における非ヒト霊長類の前臨床試験市場- スペイン
    • 研究機関における非ヒト霊長類の前臨床試験市場- オランダ
    • 研究機関における非ヒト霊長類の前臨床試験市場- オーストリア
  • 研究機関における非ヒト霊長類の前臨床試験市場- アジア太平洋
    • アジア太平洋地域：研究機関における非ヒト霊長類の前臨床試験市場、用途別、2019～2032年
    • 研究機関における非ヒト霊長類の前臨床試験市場- 中国
    • 研究機関における非ヒト霊長類の前臨床試験市場- インド
    • 研究機関における非ヒト霊長類の前臨床試験市場- マレーシア
    • 研究機関における非ヒト霊長類の前臨床試験市場- 日本
    • 研究機関における非ヒト霊長類の前臨床試験市場- インドネシア
    • 研究機関における非ヒト霊長類の前臨床試験市場- 韓国
  • 研究機関における非ヒト霊長類の前臨床試験市場-中東およびアフリカ
    • 中東およびアフリカ：研究機関における非ヒト霊長類の前臨床試験市場、用途別、2019～2032年
    • 研究機関における非ヒト霊長類の前臨床試験市場- サウジアラビア
    • 研究機関における非ヒト霊長類の前臨床試験市場-UAE
    • 研究機関における非ヒト霊長類の前臨床試験市場- イスラエル
    • 研究機関における非ヒト霊長類の前臨床試験市場- 南アフリカ
  • 研究機関における非ヒト霊長類の前臨床試験市場-ラテンアメリカ
    • ラテンアメリカ：研究機関における非ヒト霊長類の前臨床試験市場、用途別、2019～2032年
    • 研究機関における非ヒト霊長類の前臨床試験市場- メキシコ
    • 研究機関における非ヒト霊長類の前臨床試験市場- ブラジル
    • 研究機関における非ヒト霊長類の前臨床試験市場- アルゼンチン

第7章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第8章 企業プロファイル

  • ABL, Inc
  • Applied BioCode Corporation
  • BioLegend, Inc
  • Exocell, Inc
  • HUREL Corporation
  • iQ Biosciences
  • Mabtech AB
図表

List of Tables

  • Table 1 Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 2 Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 3 North America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 4 U.S.: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 5 Canada: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 6 Canada: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 7 Europe: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 8 Spain: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 9 Netherlands: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 10 Austria: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 11 Germany: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 12 Italy: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 13 France: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 14 Asia Pacific: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 15 China: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 16 Japan: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 17 India: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 18 Indonesia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 19 South Korea: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 20 Malaysia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 21 Latin America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 22 Brazil: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 23 Mexico: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 24 Argentina: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 25 Middle East & Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 26 South Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 27 Israel: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 28 Saudi Arabia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • Table 29 UAE: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Application
  • Figure 7 Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8 Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 9 Strategic Analysis - Non-Human Primate Pre-clinical studies at Contract Research Organizations Market
目次
Product Code: PM3539

The Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market size is expected to reach USD 1,08,553.86 thousands by 2032, according to a new study by Polaris Market Research. The report "Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Share, Size, Trends, Industry Analysis Report, By Application (Infectious Disease, Immunological Disease, Cancer, Others) By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Global NHP pre-clinical studies are an essential step in the development of new drugs and vaccines, and CROs provide a cost-effective solution for conducting such studies. Recent advances in genomics and other technologies have improved our understanding of NHP biology and facilitated the use of NHPs in pre-clinical studies. However, the use of NHPs in research remains controversial, and there is a growing trend toward the development of alternative methods for pre-clinical testing that do not involve the use of animals.

Recent advances in genomics and other technologies have enabled a better understanding of NHP biology and improved the development of NHP models for translational research. These advances have also facilitated the use of NHPs in pre-clinical studies, allowing for a more comprehensive assessment of the safety and efficacy of new drugs and vaccines.

NHPs in pre-clinical studies at CROs in North America has become an essential step in drug development. The integration of new technologies and the upgradation of NHP models for translational research have improved the accuracy and efficacy of NHP pre-clinical studies.

While the use of NHPs in pre-clinical studies remains controversial due to ethical concerns, CROs adhere to strict ethical guidelines and regulations to ensure the welfare of animals used in research. Additionally, CROs work closely with regulatory agencies to ensure that the pre-clinical studies meet safety and efficacy requirements before advancing to clinical trials.

CROs in Europe follow strict ethical guidelines and regulations to ensure animal welfare and regulatory agencies oversee the safety and efficacy of pre-clinical studies. While the use of NHPs in pre-clinical studies remains controversial, these studies remain an essential step in drug development.

There is a growing trend towards the upgradation of NHP models for translational research, with more focus on using NHPs that have specific disease phenotypes. For example, NHP models of Alzheimer's disease, Parkinson's disease, and HIV infection have been developed to better understand the pathogenesis of these diseases and test new treatments.

However, the use of NHPs in pre-clinical studies remains controversial, and animal rights activists continue to voice their concerns about animal welfare. Many organizations have called for the development of alternative methods for pre-clinical testing that do not involve the use of animals.

Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Report Highlights

The increasing interest in using non-human primate (NHP) based preclinical trials for research purposes has led to a significant boost in the growth of this segment.

North America witnesses the significant growth for the Non-Human Primate Pre-clinical studies at Contract Research Organizations periodically for the development and to identify cohorts of animals with specific phenotypes across centers.

The global players include: ABL, Inc., Applied BioCode Corporation, BioLegend, Inc., Exocell, Inc., HUREL Corporation, iQ Biosciences, and Mabtech AB, among others.

Polaris Market Research has segmented the Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market report based on Application and Region:

Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market,

Application Outlook (Revenue, USD Thousands, 2019-2032)

  • Infectious Disease
  • Immunological Disease
  • Cancer
  • Cardiovascular Disease
  • Metabolic Diseases
  • Genetic Disease
  • Respiratory Diseases
  • Neurological Disease
  • Female Related Diseases
  • Others

Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, Regional Outlook (Revenue - USD Thousands, 2019-2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Insights

  • 4.1. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Industry Snapshot
  • 4.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Innovations in CRISPR technologies leading to increased adoption in NHP preclinical trials
      • 4.2.1.2. Rising Geriatric Population and Rising Prevalence of Target Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Procedure Costs and Presence of Ambiguous Regulatory Framework
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Value Chain Analysis
  • 4.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Industry trends
  • 4.7. COVID-19 Impact Analysis

5. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 5.3. Infectious Disease
    • 5.3.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Infectious Disease, by Region, 2019-2032 (USD Million)
  • 5.4. Immunological Disease
    • 5.4.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Immunological Disease, by Region, 2019-2032 (USD Million)
  • 5.5. Cancer
    • 5.5.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Cancer, by Region, 2019-2032 (USD Million)
  • 5.6. Cardiovascular Disease
    • 5.6.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Cardiovascular Disease, by Region, 2019-2032 (USD Million)
  • 5.7. Metabolic Diseases
    • 5.7.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Metabolic Diseases, by Region, 2019-2032 (USD Million)
  • 5.8. Genetic Disease
    • 5.8.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Genetic Disease, by Region, 2019-2032 (USD Million)
  • 5.9. Respiratory Diseases
    • 5.9.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Respiratory Diseases, by Region, 2019-2032 (USD Million)
  • 5.10. Neurological Disease
    • 5.10.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Neurological Disease, by Region, 2019-2032 (USD Million)
  • 5.11. Female Related Diseases
    • 5.11.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Female Related Diseases, by Region, 2019-2032 (USD Million)
  • 5.12. Others
    • 5.12.1. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Geography

  • 6.1. Key findings
  • 6.2. Introduction
    • 6.2.1. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market Assessment, By Geography, 2019-2032 (USD Million)
  • 6.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - North America
    • 6.3.1. North America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.3.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - U.S.
      • 6.3.2.1. U.S.: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.3.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Canada
      • 6.3.3.1. Canada: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 6.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Europe
    • 6.4.1. Europe: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - UK
      • 6.4.2.1. UK: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - France
      • 6.4.3.1. France: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Germany
      • 6.4.4.1. Germany: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Italy
      • 6.4.5.1. Italy: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Spain
      • 6.4.6.1. Spain: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.7. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Netherlands
      • 6.4.7.1. Netherlands: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.4.8. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Austria
      • 6.4.8.1. Austria: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 6.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Asia Pacific
    • 6.5.1. Asia Pacific: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - China
      • 6.5.2.1. China: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - India
      • 6.5.3.1. India: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Malaysia
      • 6.5.4.1. Malaysia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Japan
      • 6.5.5.1. Japan: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Indonesia
      • 6.5.6.1. Indonesia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.5.7. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - South Korea
      • 6.5.7.1. South Korea: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 6.6. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Middle East & Africa
    • 6.6.1. Middle East & Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.6.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Saudi Arabia
      • 6.6.2.1. Saudi Arabia: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.6.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - UAE
      • 6.6.3.1. UAE: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.6.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Israel
      • 6.6.4.1. Israel: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.6.5. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - South Africa
      • 6.6.5.1. South Africa: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
  • 6.7. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Latin America
    • 6.7.1. Latin America: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.7.2. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Mexico
      • 6.7.2.1. Mexico: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.7.3. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Brazil
      • 6.7.3.1. Brazil: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)
    • 6.7.4. Non-Human Primate Pre-clinical studies at Contract Research Organizations Market - Argentina
      • 6.7.4.1. Argentina: Non-Human Primate Pre-clinical studies at Contract Research Organizations Market, by Application, 2019-2032 (USD Million)

7. Competitive Landscape

  • 7.1. Expansion and Acquisition Analysis
    • 7.1.1. Expansion
    • 7.1.2. Acquisitions
  • 7.2. Partnerships/Collaborations/Agreements/Exhibitions

8. Company Profiles

  • 8.1. ABL, Inc
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Development
  • 8.2. Applied BioCode Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Development
  • 8.3. BioLegend, Inc
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Development
  • 8.4. Exocell, Inc
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Development
  • 8.5. HUREL Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Development
  • 8.6. iQ Biosciences
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Development
  • 8.7. Mabtech AB
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Development